Mohammed Alquhaidan1,
Ahmed Alnaeem1,
Ahmed Omar1,
Yukio Kitade2,3,
Sara Mahmoud4,
Mahmoud Kandeel1
For correspondence:- Mahmoud Kandeel Email: mkandeel@kfu.edu.sa
Received: 18 February 2026 Accepted: 15 May 2026 Published: 31 May 2026
Citation: Alquhaidan M, Alnaeem A, Omar A, Kitade Y, Mahmoud S, Kandeel M. Clindamycin facing stewardship challenges: A bibliometric analysis of research themes and therapeutic debate. Trop J Pharm Res 2026; 25(5):723-732 doi: https://dx.doi.org/10.4314/tjpr.v25i5.14
© 2026 The authors.
This is an Open Access article that uses a funding model which does not charge readers or their institutions for access and distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0) and the Budapest Open Access Initiative (http://www.budapestopenaccessinitiative.org/read), which permit unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited..
Purpose: To explore the bibliometric overview of international literature on clindamycin, including publications, impactful authors and organizations, patterns of collaboration, and thematic changes in the last decades Methods: A bibliometric search on clindamycin was performed based on records in Scopus database. Bibliometrix and VOSviewer software were used to analyze the data. Results: Dataset included 2,651 articles based on 955 sources, with the annual growth being 7.32 % and maximum production seen in 2024. Corresponding authorship was dominated by USA, India, and China, although international collaboration was low (8.6 %). Four main thematic clusters emerged which include microbiology (methicillin-resistant Staphylococcus aureus (MRSA), inducible resistance (biofilm), dermatology (acne, topical formulations), pharmacology (pharmacokinetics, comparative efficacy), and women's health/pediatrics (bacterial vaginosis, pregnancy). Temporal analysis showed that there was a change in focus from chemotherapy to antimicrobial resistance, and diagnostic methods such as inducible clindamycin resistance test (D-test). The most cited work on clindamycin focused on therapeutic strengths, possible enteric side effects and resistance mechanisms. Conclusion: The study shows that sustained evolution of clindamycin is driven by resistant challenges and growth of therapeutic applications. This study suggests strengthening international cooperation and focusing on growing trends, such as biofilms and topical dermatologic innovations.